Brief: Ocumension Therapeutics Says Biologic License Application For Ot-702 Accepted By National Medical Products Administration
16/07/2024 17:17
July 16 (Reuters) - Ocumension Therapeutics 1477.HK :
* BIOLOGIC LICENSE APPLICATION FOR OT-702 ACCEPTED BY
NATIONAL
MEDICAL PRODUCTS ADMINISTRATION
Further company coverage: 1477.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ocumension Therapeutics
See all newsBrief: Ocumension Therapeutics Says NMPA Accepts NDA For OT-301 (NCX 470, Bimatoprost Grenod)
Brief: Ocumension Therapeutics Says Dexamethasone Intraocular Suspension Application Accepted By NMPA
Brief: Ocumension Therapeutics Says HY Adjusted Net Loss Rmb57.5 Million
China's Ocumension Therapeutics H1 revenue surges on higher ophthalmic product sales
Ocumension jumps most in three months on China nod for new drug application